Brief: Abl Texcell Diagnostics Raises Its 2026 Revenue Guidance To €13.5 Million - €14.0 Million
01/10/2026 17:07
BRIEF-Abl Texcell Diagnostics Raises Its 2026 Revenue Guidance To €13.5 Million - €14.0 Million Oct 1 (Reuters) - AbL Diagnostics SA ABLD.PA:
ABL TEXCELL DIAGNOSTICS: RAISES ITS 2026 REVENUE GUIDANCE TO €13.5 MILLION - €14.0 MILLION
Source text: ID:nBw7t9MCWa
Further company coverage: ABLD.PA
(Reporting by Zakia Mariyam)
((Zakia.Mariyam@thomsonreuters.com;))
Recent news on AbL Diagnostics SA
See all newsBrief: Abl Texcell Diagnostics Raises Its 2026 Revenue Guidance To €13.5 Million - €14.0 Million
Brief: ABL Texcell Diagnostics Announces Proposed Acquisition Of Vela Diagnostics In Singapore, US
Brief: ABL Diagnostics - Changes Name To ABL Texcell Diagnostics
Brief: ABL Diagnostics (ABLD) Announces The Filing Of A Takeover Bid For Integragen
Brief: ABL Diagnostics Delays Half-Yearly Accounts To 30 June 2023